Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients

Indian Journal of Pathology and Microbiology

Volumn 51, Issue 2, 2008, Pages 200-203

  Varaiya, Ami ^a   Kulkarni, Manasi ^a   Bhalekar, Pallavi ^a   Dogra, Jyotsana ^a  

^a SL Raheja Hospital   (India)

Author keywords

Carbapenem resistance; Metallo beta lactamase; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LOMEFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CANCER PATIENT; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DIABETIC PATIENT; DISEASE PREDISPOSITION; ESOPHAGUS CARCINOMA; FEMALE; GENERAL CONDITION DETERIORATION; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; MALE; MINIMUM INHIBITORY CONCENTRATION; PROSTATE CARCINOMA; PSEUDOMONAS AERUGINOSA; RECTUM CANCER; RESPIRATORY ARREST; SEPTICEMIA; SURVIVAL RATE; URINARY TRACT INFECTION; WOUND HEALING IMPAIRMENT;

AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASMS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 46949098447     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.41683     Document Type: Article

References (21)

1. Mendiratta DK, Deotale V, Narang P. Metallo beta Lactamase producing Pseudomonas aeruginosa in a hospital from rural area. Indian J Med Res 2005;121:701-3.
2. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res 2006;124:95-8.
3. Gladstone P, Rajendran P, Brahmadathan KN. Incidence of carbapenem resistant nonfermenting Gram negative bacilli from patients with respiratory infections in the intensive care unit. Indian J Med Microbiol 2005;23:189-91.
4. Bush K. Metallo β-lactamase: A class apart. Clin Infect Dis 1998;27:S48-53.
5. Bennett PM. Integrons and gene cassettes: A genetic construction Kit for bacteria. Antimicrob Agents Chemother 1999;43:1-4.
6. Bush K, Jacoby GA, Medeiros A. A functional classification scheme for beta lactamase and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-33.
7. th ed. New York: Mosby; 1998. p. 167-87.
8. Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. 9th ed. Vol.26, 2006. p. M2-A9.
9. Hemalatha V, Sekar U, Kamat V. Detection of Metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2005;122:148-52.
10. Yano H, Kuga A, Okamota R, Kitasato H, Kobayashi T, Inon M. Plasid coded Metallo betalactamase (imp 6) conferring resistance to carbapenems, especially meropenam. Antimicrob Agents Chemother 2001;45:1343-8.
11. Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbial Infect Dis 1998;17:73-7.
12. Gonlugur U, Bakiri MZ, Akkurt I, Efeoglu T. Antibiotic susceptibility patterns among respiratory isolates of gram negative bacilli in a Turkish University Hospital. BMC Microbiol 2004;4:32-6.
13. Navneeth BV, Sridaran D, Sahay D, Belwadi M. A preliminary study on Metallo betalactamse producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2002;116:264-7.
14. Taneja N, Aharwal S.M, Sharma M. Imipenem Resistance in non fermenters causing nosocomial urinary tract infection. Indian J Med Sci 2003;57:294-9.
15. Jesudason MV, Kandathil AJ, Balaji V. Comparison of two methods to detect carbapenemase and metallo-β-lactamase production in clinical isolates. Indian J Med Res 2005;121:780-3.
16. Sarkar B, Biswas D, Prasad R, Sharma JP. A clinicalmicrobiological study on the importance of Pseudomonas in nosocomially infected ICU patients, with special reference to metallo β-lactamase production. Indian J Patho Microbiol 2006;49:44-8.
17. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo β-lactamase: The Quiet before the Storm? Clin Microbiol Rev 2005;18:306-25.
18. Marra AR, Pereira CA, Gales AC, Menezes LC, Cal RG, de Souza JM, et al. Bloodstream infections with metallo-lactamase-producing Pseudomonas aeruginosa: Epidemiology, microbiology and clinical outcomes. Antimicrob Agents Chemother 2006;50:388-90.
19. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinicomicrobiological study of diabetic foot ulcers in an Indian Tertiary Care Hospital. Diabetes Care 2006;29:1727-32.
20. Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in 1990s. Eur J Clin Microbiol Infect Dis 2000;19:15-25.
21. Endimiani A, Luzzaro F, Pini B, Amicosante G, Rossolini GM, Toniolo AQ. Pseudomonas aeruginosa bloodstream infections: Risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase. BMC Infect Dis 2006;6:52.